Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kymera Therapeutics, Inc.

KYMR Clue Score27

United States Fiscal year ends December CIK 0001815442 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

14 insiders · 267 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bruce Booth

Director

—

$217.75M (146) scheduled

−$217.75M

466,077

0.5605%

$54.12M

−81.5%

Bvf Partners L P/Il entity

Director

—

$173.67M (4)

−$173.67M

318,910

0.3835%

$37.03M

−80.5%

Baker Bros. Advisors LP entity

Director

$172.50M (2)

—

+$172.50M

7,955,916

9.57%

$923.84M

+50.3%

Nello Mainolfi

Chief Executive Officer

—

$34.99M (23) scheduled

−$34.99M

666,568

0.8016%

$77.40M

+2.4%

Jeremy G Chadwick

Chief Operating Officer

—

$15.60M (29) scheduled

−$15.60M

44,018

0.0529%

$5.11M

−4.6%

Bruce N. Jacobs

Chief Financial Officer

—

$9.96M (15) scheduled

−$9.96M

244,883

0.2945%

$28.44M

+44.2%

Jared Gollob

Chief Medical Officer

—

$5.29M (13) scheduled

−$5.29M

117,134

0.1409%

$13.60M

+22.3%

Pamela Esposito

Director

—

$3.05M (12) scheduled

−$3.05M

1,000

0.0012%

$116.12K

—

Noah Goodman

Chief Business Officer

—

$2.22M (9) scheduled

−$2.22M

47,179

0.0567%

$5.48M

+10,282%

Elena Ridloff

Director

—

$1.29M (4) scheduled

−$1.29M

0

0.0000%

$0.00

—

Brian Adams

Chief Legal Officer

—

$744.30K (3)

−$744.30K

50,254

0.0604%

$5.84M

—

Jeffrey W. Albers

Director

—

$448.82K (2) scheduled

−$448.82K

0

0.0000%

$0.00

—

Ellen Chiniara

Chief Legal Officer

—

—

—

80,085

0.0963%

$9.30M

+38.2%

Terence Rooney

Chief Medical Officer

—

—

—

38,000

0.0457%

$4.41M

—